Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorGARCIA-LAYANA, Alfredo
dc.contributor.authorGARHOFER, Gerhard
dc.contributor.authorASLAM, Tariq M.
dc.contributor.authorSILVA, Rufino
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDELCOURT, Cecile
ORCID: 0000-0002-2099-0481
IDREF: 035105291
dc.contributor.authorKLAVER, Caroline C. W.
dc.contributor.authorSEDDON, Johanna M.
dc.contributor.authorMINNELLA, Angelo M.
dc.date.accessioned2022-01-14T09:16:26Z
dc.date.available2022-01-14T09:16:26Z
dc.date.issued2021-11-20
dc.identifier.issn2077-0383 (Print) 2077-0383 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/124385
dc.description.abstractEnBACKGROUND: Early identification of AMD can lead to prompt and more effective treatment, better outcomes, and better final visual acuity; several risk scores have been devised to determine the individual level of risk for developing AMD. Herein, the Delphi method was used to provide recommendations for daily practice regarding preventive measures and follow-up required for subjects at low, moderate, and high risk of AMD evaluated with the Simplified Test AMD Risk-assessment Scale (STARS(®)) questionnaire. METHODS: A steering committee of three experts drafted and refined 25 statements on the approach to be recommended in different clinical situations [general recommendations (n = 2), use of evaluation tools (n = 4), general lifestyle advice (n = 3), and AREDS-based nutritional supplementation (n = 5)] with the help of a group of international experts, all co-authors of this paper. Thirty retinal specialists from Europe and the US were chosen based on relevant publications, clinical expertise, and experience in AMD, who then provided their level of agreement with the statements. Statements for which consensus was not reached were modified and voted upon again. RESULTS: In the first round of voting, consensus was reached for 24 statements. After modification, consensus was then reached for the remaining statement. CONCLUSION: An interprofessional guideline to support preventive measures in patients at risk of AMD based on STARS(®) scoring has been developed to aid clinicians in daily practice, which will help to optimize preventive care of patients at risk of AMD.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enAge-related macular degeneration
dc.subject.enPrevention
dc.subject.enIdentification
dc.subject.enRisk
dc.subject.enDelphi
dc.subject.enSTARS®
dc.subject.enFood supplement
dc.title.enExploring Consensus on Preventive Measures and Identification of Patients at Risk of Age-Related Macular Degeneration Using the Delphi Process
dc.typeArticle de revueen_US
dc.identifier.doi10.3390/jcm10225432en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed34830713en_US
bordeaux.journalJournal of Clinical Medicineen_US
bordeaux.volume10en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue22en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamLEHA_BPH
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03525861
hal.version1
hal.date.transferred2022-01-14T09:16:35Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Clinical%20Medicine&rft.date=2021-11-20&rft.volume=10&rft.issue=22&rft.eissn=2077-0383%20(Print)%202077-0383%20(Linking)&rft.issn=2077-0383%20(Print)%202077-0383%20(Linking)&rft.au=GARCIA-LAYANA,%20Alfredo&GARHOFER,%20Gerhard&ASLAM,%20Tariq%20M.&SILVA,%20Rufino&DELCOURT,%20Cecile&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée